Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1966 3
1967 2
1968 5
1969 1
1970 1
1971 2
1972 1
1975 1
1976 2
1979 1
1981 3
1982 2
1983 3
1985 1
1986 1
1987 3
1988 9
1989 1
1990 4
1991 2
1992 4
1993 3
1994 12
1995 11
1996 15
1997 16
1998 18
1999 14
2000 7
2001 13
2002 10
2003 14
2004 14
2005 8
2006 12
2007 14
2008 13
2009 15
2010 19
2011 20
2012 21
2013 32
2014 36
2015 21
2016 24
2017 22
2018 23
2019 27
2020 33
2021 41
2022 34
2023 30
2024 36

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

599 results

Results by year

Filters applied: . Clear all
Page 1
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial.
Bardia A, Messersmith WA, Kio EA, Berlin JD, Vahdat L, Masters GA, Moroose R, Santin AD, Kalinsky K, Picozzi V, O'Shaughnessy J, Gray JE, Komiya T, Lang JM, Chang JC, Starodub A, Goldenberg DM, Sharkey RM, Maliakal P, Hong Q, Wegener WA, Goswami T, Ocean AJ. Bardia A, et al. Among authors: komiya t. Ann Oncol. 2021 Jun;32(6):746-756. doi: 10.1016/j.annonc.2021.03.005. Epub 2021 Mar 16. Ann Oncol. 2021. PMID: 33741442 Free article. Clinical Trial.
Pembrolizumab Plus Concurrent Chemoradiation Therapy in Patients With Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: The Phase 2 KEYNOTE-799 Nonrandomized Trial.
Jabbour SK, Lee KH, Frost N, Breder V, Kowalski DM, Pollock T, Levchenko E, Reguart N, Martinez-Marti A, Houghton B, Paoli JB, Safina S, Park K, Komiya T, Sanford A, Boolell V, Liu H, Samkari A, Keller SM, Reck M. Jabbour SK, et al. Among authors: komiya t. JAMA Oncol. 2021 Jun 4;7(9):1-9. doi: 10.1001/jamaoncol.2021.2301. Online ahead of print. JAMA Oncol. 2021. PMID: 34086039 Free PMC article.
Bisalbuminemia in nephrotic syndrome.
Ogawa M, Toda N, Kurahashi S, Fujita K, Tanigaki K, Hirashima H, Fujita M, Komiya T. Ogawa M, et al. Among authors: komiya t. Kidney Int. 2022 Oct;102(4):943. doi: 10.1016/j.kint.2022.04.039. Kidney Int. 2022. PMID: 36150771 No abstract available.
Aortic valve repair update.
Komiya T. Komiya T. Gen Thorac Cardiovasc Surg. 2015 Jun;63(6):309-19. doi: 10.1007/s11748-015-0523-1. Epub 2015 Feb 5. Gen Thorac Cardiovasc Surg. 2015. PMID: 25652725 Review.
Advances in the Treatment of Mucoepidermoid Carcinoma.
Sama S, Komiya T, Guddati AK. Sama S, et al. Among authors: komiya t. World J Oncol. 2022 Feb;13(1):1-7. doi: 10.14740/wjon1412. Epub 2021 Dec 8. World J Oncol. 2022. PMID: 35317327 Free PMC article. Review.
Ehrlichia ruminantium, Sudan.
Muramatsu Y, Ukegawa SY, Rahim A, El Hussein M, Abdel Rahman MB, Abdel Gabbar KM, Chitambo AM, Komiya T, Mwase ET, Morita C, Tamura Y. Muramatsu Y, et al. Among authors: komiya t. Emerg Infect Dis. 2005 Nov;11(11):1792-3. doi: 10.3201/eid1111.050744. Emerg Infect Dis. 2005. PMID: 16422005 Free PMC article. No abstract available.
Response to Bao et al.
Komiya T, Takamori S, Wilding G. Komiya T, et al. Radiother Oncol. 2022 Dec;177:251. doi: 10.1016/j.radonc.2022.10.031. Epub 2022 Nov 9. Radiother Oncol. 2022. PMID: 36334691 No abstract available.
599 results